Follow
Rottoli P
Title
Cited by
Cited by
Year
Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis
A Prasse, C Probst, E Bargagli, G Zissel, GB Toews, KR Flaherty, ...
American journal of respiratory and critical care medicine 179 (8), 717-723, 2009
3722009
Oxidative stress in the pathogenesis of diffuse lung diseases: a review
E Bargagli, C Olivieri, D Bennett, A Prasse, J Muller-Quernheim, P Rottoli
Respiratory medicine 103 (9), 1245-1256, 2009
2672009
Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
M Mura, MA Porretta, E Bargagli, G Sergiacomi, M Zompatori, ...
European Respiratory Journal, erj01060-2011, 2012
2332012
Phenotypes of organ involvement in sarcoidosis
JC Schupp, S Freitag-Wolf, E Bargagli, V Mihailović-Vučinić, P Rottoli, ...
European Respiratory Journal 51 (1), 1700991, 2018
1722018
Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary …
P Rottoli, B Magi, MG Perari, S Liberatori, N Nikiforakis, E Bargagli, ...
Proteomics 5 (5), 1423-1430, 2005
1652005
Proteome analysis of bronchoalveolar lavage in lung diseases
B Magi, E Bargagli, L Bini, P Rottoli
Proteomics 6 (23), 6354-6369, 2006
1312006
BAL cell gene expression is indicative of outcome and airway basal cell involvement in IPF
A Prasse, H Binder, JC Schupp, G Kayser, E Bargagli, B Jaeger, M Hess, ...
American journal of respiratory and critical care medicine, 2018
1252018
Human chitotriosidase: a sensitive biomarker of sarcoidosis
E Bargagli, D Bennett, C Maggiorelli, P Di Sipio, M Margollicci, N Bianchi, ...
Journal of clinical immunology 33 (1), 264-270, 2013
1152013
Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis
P Rottoli, B Magi, R Cianti, E Bargagli, C Vagaggini, N Nikiforakis, ...
Proteomics 5 (10), 2612-2618, 2005
1112005
Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas
E Bargagli, A Mazzi, P Rottoli
Clinics in chest medicine 29 (3), 445-458, 2008
1052008
Analysis of serum amyloid A in sarcoidosis patients
E Bargagli, B Magi, C Olivieri, N Bianchi, C Landi, P Rottoli
Respiratory medicine 105 (5), 775-780, 2011
902011
Quality of life, anxiety and depression in sarcoidosis
A Goracci, A Fagiolini, M Martinucci, S Calossi, S Rossi, T Santomauro, ...
General hospital psychiatry 30 (5), 441-445, 2008
832008
Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis.
S Grosso, MA Margollicci, E Bargagli, QR Buccoliero, A Perrone, ...
Scandinavian journal of clinical and laboratory investigation 64 (1), 57-62, 2004
832004
Chitotriosidase and soluble IL‐2 receptor: Comparison of two markers of sarcoidosis severity
E Bargagli, N Bianchi, M Margollicci, C Olivieri, A Luddi, G Coviello, ...
Scandinavian journal of clinical and laboratory investigation 68 (6), 479-483, 2008
812008
Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis
E Bargagli, M Margollicci, N Nikiforakis, A Luddi, A Perrone, S Grosso, ...
Respiration 74 (5), 548-552, 2007
782007
Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis
E Bargagli, M Galeazzi, P Rottoli
European Respiratory Journal 24 (4), 708-708, 2004
722004
Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension
E Bargagli, M Galeazzi, F Bellisai, L Volterrani, P Rottoli
Respiration 75 (3), 346-349, 2008
712008
A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls
C Landi, E Bargagli, A Carleo, L Bianchi, A Gagliardi, A Prasse, MG Perari, ...
PROTEOMICS–Clinical Applications 8 (11-12), 932-950, 2014
652014
Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors
L Voltolini, S Bongiolatti, L Luzzi, E Bargagli, A Fossi, C Ghiribelli, ...
European Journal of Cardio-Thoracic Surgery 43 (1), e17-e23, 2012
642012
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis
C Landi, E Bargagli, L Bianchi, A Gagliardi, A Carleo, D Bennett, ...
Journal of proteomics 83, 60-75, 2013
632013
The system can't perform the operation now. Try again later.
Articles 1–20